---
title: "Astrazeneca Uk Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/418262bf-abfc-4e8b-a8b4-6ecf5eb55d65
json: https://whiteintel.dev/api/public/dossier/418262bf-abfc-4e8b-a8b4-6ecf5eb55d65
identifier: gb-coh:3674842
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Astrazeneca Uk Limited

**Type:** Company  
**Jurisdiction:** GB  
**Identifier:** `gb-coh:3674842`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/418262bf-abfc-4e8b-a8b4-6ecf5eb55d65  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/418262bf-abfc-4e8b-a8b4-6ecf5eb55d65  

## Cross-source identity

The same real-world entity, resolved across sources:

- **ASTRAZENECA UK LIMITED** — GLEIF · `lei:549300VDUBM78UTDVB73` — https://whiteintel.dev/entity/f04c0b1c-086b-5c9e-8df7-9d24d7de8e01
- **ASTRAZENECA UK LIMITED** — companies_house_bulk · `oo:GB-COH-03674842` — https://whiteintel.dev/entity/470a8049-6750-5b53-a977-dabd80cc8ebd

## Ownership & control

### Holdings / subsidiaries

- **MEDIMMUNE U.K. LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/f32a9b71-df4b-476d-80e4-38a73b03884b
- **KUDOS PHARMACEUTICALS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/c7a28e9c-c056-48d0-8395-4d3102c44963
- **ARROW THERAPEUTICS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/82ed42dc-de4a-53bb-9cd2-e42222e527b3
- **ASTRAZENECA NOMINEES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/7b01105e-accb-584c-a79b-db7939a811a0
- **ASTRAZENECA DEATH IN SERVICE TRUSTEE LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/26bc89f1-e35c-5ed7-b497-389fcdd07e77
- **ASTRAZENECA JAPAN LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/e08b34db-4cc1-50a1-92f6-6065033ea409
- **ASTRAZENECA EMPLOYEE SHARE TRUST LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/ed44579c-3da6-51c0-8b51-f949e2202249
- **BRITISH PHARMA GROUP LIMITED** (beneficial owner) — https://whiteintel.dev/entity/44928f84-37a2-5b1a-adfe-0fffd0503bd8
- **ASTRAZENECA TREASURY LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff
- **ASTRAZENECA SHARE TRUST LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/ca4f99fe-9143-5788-b166-fdc5558cebbe
- **Randall & Quilter Investment Holdings Ltd.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/e429657b-9b93-5589-b226-bd1c6ec59818
- **EVINOVA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/2d8f51d5-2063-50bb-846b-64791e3c0097
- **ASTRAZENECA INVESTMENTS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/239f0f3d-d24f-5c47-a298-6c6fcf8e8d7e

### UBO chain (walk to the ultimate owner)

A **4-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `03674842`
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 1998-11-26
- **Registered office:** 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA
- **SIC:** 70100 - Activities of head offices

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Astrazeneca Uk Limited**. Human view: https://whiteintel.dev/entity/418262bf-abfc-4e8b-a8b4-6ecf5eb55d65 · Structured JSON: https://whiteintel.dev/api/public/dossier/418262bf-abfc-4e8b-a8b4-6ecf5eb55d65._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._